1
Clinical Trials associated with CircFam53B-219aa DC vaccine(Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University)A Single Arm Clinical Study of Dendritic Cell Vaccine Loaded With Circular RNA Encoding Cryptic Peptide for Patients With HER2-negative Advanced Breast Cancer
The purpose of this clinical trial is to understand the safety and tolerability of CircFAM53B-219aa DC vaccine monotherapy and its combination with camrelizumab in the treatment of HER2-negative advanced breast cancer, as well as to evaluate its efficacy.
100 Clinical Results associated with CircFam53B-219aa DC vaccine(Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University)
100 Translational Medicine associated with CircFam53B-219aa DC vaccine(Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University)
100 Patents (Medical) associated with CircFam53B-219aa DC vaccine(Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University)
100 Deals associated with CircFam53B-219aa DC vaccine(Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University)